EMCC European Monitoring Centre on Change

Wyeth Pharmaceuticals

Company/Organisation:
Wyeth Pharmaceuticals

Geographic Location

Country: Belgium
Region: Région Wallonne
Location of affected unit(s): Louvain-la-Neuve

Company

Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number Employed: 174
Group: Pfizer

Employment Effects

Announcement Date: 27-11-2009
Planned Job Reductions min: 104
Planned Job Reductions max: 104
Type of Restructuring: Merger/Acquisition

Additional Information

Belgian management of Wyeth, a company operating in the pharmaceutical industry, announced the cut of 120 jobs at its site in Louvain-la-Neuve. The announcement was made at an extraordinary works council meeting and concerns 69% of all employees mainly in administration, marketing and sales. Since October 2009, Wyeth is a subsidiary of Pfizer.

The number of job losses was reduced to 104 at the second official redundancy notification in March 2010.